Although further studies are needed to characterize the molecular mechanism of CRPC transition and PCa progression, our findings suggest that ACTN4 is involved in advancement of the EMT potential of PCa cells and acquisition of the aggressive cancer properties. The gene discussed is ACTN4; the disease is cancer.